NewYork-Presbyterian/Columbia University Medical Center (CUMC) recently unveiled a state-of-the-art mobile testing unit in a push to reduce blindness-causing eye diseases across the city. The unit, called The Tele-Ophthalmology Unit, is the first of its kind in the country, targeting communities where residents are most vulnerable to four major sight-threatening conditions: glaucoma, cataracts, macular degeneration and diabetic retinopathy.

NewYork-Presbyterian Lawrence Hospital Orthopedics is undergoing an exciting transformation, ushered in by nationally renowned sports medicine and orthopedic physicians from Columbia University Medical Center (CUMC). Doctors will be seeing patients in Bronxville and Tarrytown, with surgical procedures performed at NewYork-Presbyterian Lawrence Hospital.

NewYork-Presbyterian Lawrence Hospital and Gilda’s Club Westchester are partnering on a new program that will bring Gilda’s Club Westchester’s widely acclaimed cancer support services to the Bronxville-based hospital.

NewYork-Presbyterian is deploying a Disaster Response Team to Puerto Rico today to help provide much-needed medical care for residents still suffering in the aftermath of Hurricane Maria. Our medical team includes four physicians and eight nurses with diverse areas of expertise.

Mendel Goldfinger, MD, and A. James D’Silva, MD, both specialists in the treatment of patients with cancer, recently joined NewYork-Presbyterian Brooklyn Methodist Hospital’s Division of Hematology/Oncology.

Dr. Roshni Rao, a renowned expert in breast care, has been appointed chief of the Breast Surgery Program at NewYork-Presbyterian/Columbia University Medical Center, effective October 3. She will also serve as associate professor of surgery at Columbia University College of Physicians and Surgeons.

On Monday, August 21, NewYork-Presbyterian Brooklyn Methodist Hospital opened the doors of a new pediatric practice site at 621 Degraw Street. The space is replacing the Hospital’s shuttered pediatric practice at One Prospect Park West.

Internationally renowned neuro-oncologist Dr. Howard A. Fine of Weill Cornell Medicine and NewYork-Presbyterian will receive a five-year, $6 million National Institutes of Health Director’s Pioneer Award for brain cancer research. Established in 2004, NIH Director’s Pioneer Awards, part of the NIH Common Fund, will provide nearly $1.2 million annually for five years to a single principal investigator who has demonstrated exceptional creativity and is pursuing a bold new research strategy against a major biomedical challenge.